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Stlmm~'y 
Mls-1 is an endogenous superantigen  that leads to in vivo deletion and in vitro stimulation of 
T cell receptor (TCR) V/36-, 7-, 8.1-, and 9-expressing cells. The MA/MyJ mouse deletes the 
identical set of TCR from its mature T cell repertoire; however, it does not contain Mtv-7, the 
murine mammary tumor provirus (MMTV), whose sag gene encodes Mls-1. Interestingly,  the 
superantigen activity of this mouse strain segregates with a new mammary tumor provirus, Mtv- 
43, not seen in other inbred strains. The predicted amino acid sequence of the sag gene of Mtv-43 
was compared with that of Mtv-7.  Strikingly,  the COOH terminus of the two molecules is 
very similar, while all other MMTV-encoded superantigens  differ 100% in this segment. 
T 
he endogenous superantigens (SAG)  1 comprise a family 
of  molecules that exert a strong influence on the expressed 
TCR repertoire. Unlike conventional peptide antigens, which 
contact the third hypervariable region of both the ot and the 
chains of the TCR, SAG are recognized by the TCR V/$ 
gene product only (1). The prototype of an endogenous SAG 
is Mls-1, which was discovered some 20 yr ago by Pesten- 
stein (2). The biochemical nature of this ligand,  however, 
remained an enigma until recently. The first breakthrough 
came from two independent groups who established  that Mls- 
1-expressing mice delete TCR V/~6  + and V/58.1 + T  cells 
from their mature repertoire. These investigators also observed 
that V/$6 and V~8.1  T cells respond to Mls-1 stimulation 
in vitro (3, 4). Similar results were obtained with other en- 
dogenous  SAG  (5-9).  The  genetic mapping  of a  V~5- 
tolerizing element close to  the murine mammary tumor 
provirus  (MMTV) Mtv-9 provided a hint of the molecular 
nature of the endogenous SAG (10). This led us and others 
to map a series of endogenous SAG to various MMTV loci 
and infectious MMTV (11-14). Furthermore, the open reading 
frame in the U3 region of  the MMTV LTR has been identified 
as the gene encoding the SAG (15-18a). Thus, the new name 
MMTV sag has been proposed for this retroviral gene (18a). 
In our initial survey of the correlation between the pres- 
ence of Mtv-7 and the expression of an Mls-1 phenotype in 
inbred mice, we noticed one discrepancy,  namely, the MA/MyJ 
strain that had been typed as Mls-1 positive (19, 20), but lacks 
Mtv-7 (11). Intrigued by this observation,  we analyzed the 
SAG activity of this mouse strain in detail We described in 
this report striking similarities, as well as some differences, 
between the Mls-1 and the MA/MyJ-specific T cell stimula- 
tory/tolerizing phenotypes. Using backcross segregation anal- 
yses, we were able to map the SAG activity of this mouse 
strain to a new MMTV, now called Mtv-43,  which is not 
present  in other inbred strains tested to date. 
We have determined the nudeotide sequence of Mtv-43 sag 
and compared its predicted amino acid sequence with that 
of other MMTV sag genes. The Mtv-7 and the Mtv-43 sag-en- 
coded proteins are very similar. Most strikingly, their COOH 
terminus is very similar, while other MMTV sag-encoded 
proteins differ 100% in this segment. Thus, we conclude that 
this region is responsible for the TCK V~ specificity that 
is shared between the Mtv-7- and the Mtv-43-encoded  SAG. 
Interestingly, the predicted amino acid sequence of the Mtv- 
43 sag is closely  related to that of an exogenous MMTV, which 
functionally resembles Mls-1 (20a). 
Materials and Methods 
1 Abbreviations  used  in  this  paper:.  MMTV, murine  mammary  tumor  Mice.  MA/MyJ, B10.BR, CBA/J, AKR, and C3H/HeJ mice 
provirus; SAG, superantigens,  were purchased  from The Jackson Laboratory  (Bar Harbor, ME). 
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and B10.BR x  (MA/MyJ  x  B10.BR)F1 were bred at the animal 
facilities at Tufts University School of Medicine. 
Antibodies.  The following cytotoxic mAbs for C killing were 
obtained from American Type  Culture Collection (Rockvilh, MD) 
anti-CD4  (ILL 172), anti-CD8  (3.155), anti-HSA (J11D), anti- 
I-A  k (10.2-16), and anti-I-E  k (M5-114.25.2). Anti-VB mAbs were 
obtained from the following sources: V~2 (B20.6), B. Mallissen 
(Marseilles, France); VB3 (KJ25) and V~8.1  +  VBS.2 (KJ16), P. 
Marrack andJ. Kappler  (Denver, CO); VB4 (KT4.10), K. Tomonari 
(London, UK); V/~6 (44.22.1), H. Hengartner (Zurich, Switzer- 
land); VB7 (TR130), I. Weissman (Stanford, CA); VBS.2 (F23.2); 
M. Bevan (Seattle, WA); and VB9 (MR10.2), O. Kanagawa (St. 
Louis, MO). They were all used in biotinylated form. Anti-CD4 
(GK1.5) and anti-CD8 (53-6.72) were obtained  from American  Type 
Culture  Collection and used in FITC-conjugated form. 
Oligonucleotides.  Six oligonucleotides  were synthesized  for this 
study. Two 23mers were used as primers for the PCR: a 5' primer 
(position 343-357) 5'-AATTCGGACCACAGCCAACT-3'  includes 
an EcoRI restriction site, and a 3' primer (position 1107-1121) 
5'-GATCTCCAAGTCAGGAAACC-3'  includes a BgllI restriction 
site. Two oligomers were used for sequencing: a 15mer (position 
691-705) 5'-ATCTGTTGGTCT-3', and a 2liner (position 925-945) 
5'-TCCCTCTTCGGTGTACTC-3'. An Mtv-7 sag-specific 21met 
(position 982-1003) 5'-GAAGCCAACGCGACCCCC-3' and an 
Mlr-43 sag-specific 18mer (position  978-995) 5'-ATGCGACCGTT- 
ATGA-3' were used for hybridizations. 
MLR.  Single  cell spleen suspensions were prepared, and the 
red cells were lysed by hypotonic shock. B cell blast stimulators 
were obtained  by treating spleen cells  with anti-CD4 and anti-CD8 
mAb plus guinea pig C (Organon Teknika-Cappel, West Chester, 
PA) for 30 min at 37~  followed  by a 18-24-h incubation in RPMI 
(Gibco Laboratories,  Grand Island, NY), supplemented  with Hepes, 
2-ME, 2 mM t-glutamine (Gibco Laboratories), 100 U/ml peni- 
cillin and 100/~g/ml streptomycin (Gibco Laboratories), 10% FCS 
(Hazelton, Lenexa,  KA), and 10/xg/ml LPS (Sigma Chemical Co., 
St. Louis, MO). B cell blasts were treated with mitomycin C (75 
/~g/ml) (Sigma Chemical Co.) before coculture with T cells. T cell 
responders were prepared by passage through nylon wool. MLR 
were carried out in 96-well plates by incubating 5  x  10  s B cell 
blasts and 2  x  10  s T  cells in 200  #1 Click's medium (Irvine 
Scientific, Neptune, NJ), supplemented with t-glutamine, peni- 
cillin, streptomycin, and 5% prescreened FCS (kindly provided by 
C. Janeway, New Haven, CT). The cells were incubated at 37~ 
in 7% CO2 for 72-86 h, with 1/~C [3H]TdR (New England Nu- 
clear, Boston, MA) added for the last 12 h. The plates were har- 
vested  using a PHDcell harvester (Cambridge Technologies,  Water- 
town, MA), and incorporation of [3H]TdR into the DNA was 
counted on a B counter (Beckman  Instruments, Inc., Fullerton,  CA). 
Flow Cytometry.  Two-color  fluorescence  analyses  were carried 
out on T cells that had been isolated from whole spleen cells by 
treatment with anti-I-A  k or anti-I-E  k and anti-HSA mAb plus a 
mixture of guinea pig C and rabbit C (Pel-Freez Clinical Systems, 
Brown Deer, WI) for 20 min at 37~  followed  by a second incu- 
bation with C for 20 rain at 37~  Cells were then incubated with 
the various biotinylated anti-VB mAbs for 20 min on ice, washed, 
and incubated with FITC-conjugated anti-CD4 or anti-CD8 mAb 
and PE streptavidin (Southern Biotechnology Associates, Inc., Bir- 
mingham, AL) for 20 min on ice. The cells were analyzed using 
the FACScan  |  (Becton Dickinson & Co., Mountain View, CA). 
Southern Analyses.  DNA was isolated from whole spleen cells, 
digested with PvulI (Gibco BRL, International Biotechnologies, 
Inc., New Haven, CT), and subjected  to electrophoresis  on an 0.8% 
Seakem (FMC BioProducts, Rockland, ME) agarose gel 21-23 h 
at 60 V, as previously described (11). The gel was denatured in 
0.2 M NaOH, 0.75 M Tails, and neutralized in 1 M NaC1, 1.5 M 
Tris. For Southern analyses, the gel was blotted  onto Zetabind 
(CUNO, Inc., Meriden, CT) or Biotrans (ICN Biomedicals, Inc., 
Irvine, CA) nylon over night in 20x  SSC. The DNA was UV 
crosslinked  to the nylon, and washed for 1 h at 65~  in 0.1x  SSC, 
0.5% SDS. The blots were prehybridized  for I h at 65~  and then 
hybridized with a random-primed MMTV LTR probe (21) for 
16-18 h at 65~  The blots were washed and exposed for 1-3 d 
at  -80~  on x-ray film. For oligonucleotide hybridizations, the 
agarose gel was dried, prehybridized for 1 h at 37~  and then 
hybridized with an end-labeled  oligomer for 16-18 h at 37~  ac- 
cording to published procedures (22). The gel was washed and ex- 
posed for 4-7 d at  -80~  on x-ray film. 
PCR Amplification, Cloning~ and Sequencing of Mtv-43 sag.  The 
DNA for PCR was obtained by separating PvuII-digested DNA 
in low-melt agarose and isolating the band corresponding in size 
to the Mtv-43 junction fragment (between 6.1 and 6.7 kb). The 
DNA was amplified  by PCR (Perkin Elmer Cetus, Norwalk, CT) 
using the two primers described above. The PCR product was 
digested with EcoRI and BgllI (Gibco BRL, International Biotech- 
nologies, Inc.) and cloned into M13mp18 (New England Biolabs, 
Beverly, MA). Competent  XLl-blue-Escherichia coli were trans- 
formed with the double-stranded phage. Phage plaques that hy- 
bridized to an MMTV LTR probe were picked for sequencing. 
Single-strand  phage DNA was prepared by PEG precipitation from 
an over night culture. The DNA was sequenced  using the Sequenase 
Kit (U.S. Biochemical  Corp., Cleveland,  OH) and both the M13-40 
primer (U.S. Biochemical Corp.) and the two MMTV  specific 
oligomers described above. 
Results 
Mls  Phenotype  of the  MA/MyJ  Mouse.  Although  the 
MA/MyJ mouse has been described as having an Mls-1 pheno- 
type (19), Ryan et al. (20) noted that T cells from this mouse 
strain are stimulated by H-2-matched spleen cells of an Mls-1 
strain. Furthermore, we have established that MA/MyJ lacks 
Mtv-7 (11), the endogenous MMTV that encodes Mls-1 (18a). 
These observations prompted us to further investigate the 
Mls phenotype of the MA-MyJ strain. Using H-2-matched 
stimulator and responder cells (see Table 1), we have confirmed 
Table  1.  1-1-2  and Mls Phenotypes of Mouse Strains Used 
H-2  Mls 
MA/MyJ  k  ? 
B10.BR  k  - 
AKR  k  1 
CBA/J  k  1,  3 
C3H  k  3, 4 
BALB/c  d  3 
Mls-1 (Mtv.7) is a VB6, VB7, VB8.1, and VB9 deleting  phenotype;  Mls-3 
and Mls-4 (Mtv-6 and Mtv-1, respectively)  are V83 deleting  phenotypes. 
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Figure 1.  Primary MLR. (.4) Respome ofT cells from four H-2-matched 
strains and one H-2-mismatched strain to LPS-activated B cells from B10.BR 
and MA/MyJ mice, respectively. (/3) Response of B10.BR and MA/MyJ 
T  cells to LPS-activated B cells from four H-2-matched  strains and one 
H-2-mismatched  strain, cpm is of [3H]TdR incorporation. 
and extended the finding of Kyan et al. (20).  B cells from 
MA/MyJ mice induced a primary MLR in CBA/J-, AKK-, 
and C3H-derived T cells, as depicted in a representative ex- 
periment in Fig. 1 A. Stimulator cells were preactivated with 
LPS, because this treatment is known to increase the stimula- 
tory capacity of endogenous SAG (10). Although the stimula- 
tory activity of MA/MyJ  B cells  is relatively  small in the 
strain combinations tested,  it is very reproducible.  In addi- 
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Figure 2.  Age-related appearance of stimulatory activity. The stimula- 
tory capacity of LPS-activated B cells from (MA/MyJ  x  B10.BR)F1 mice 
in a primary MLR, measured on B10.BR T  cells, is seen reliably only 
by 12-14 wk, and is further enhanced with increasing age. 
tion, MA/MyJ T cells responded to LPS-stimulated  B cells 
from AKR and CBA/J mice (Fig.  1 B). From these results, 
we conclude that MA/MyJ mice do not express a strict Mls-1 
phenotype. Interestingly, the stimulatory activity of MA/MyJ 
B  cells  is  seen  only by  12-14 wk of age (Fig.  2).  This is 
significantly later in ontogeny than the manifestation of the 
Mls-1 phenotype (23), but resembles the appearance of SAG 
activity induced by infectious MMTV  (15,  16). 
TCR V~ Repertoire  of tke MA/MyJ Mouse.  Since endog- 
enous SAG lead to deletion of T cells expressing certain TCR 
V/3 genes (3, 4, 6, 24-26), we analyzed the TCR V~ reper- 
toire in the peripheral T cells of the MA/MyJ mouse. A com- 
parison was carried out with T cells from H-2-matched AKR 
and B10.BR mice. Using two-color flow cytometry,  the ex- 
pression of eight V~/chains was analyzed in CD4 + as well 
as in CD8 + T  cells.  While no significant  differences were 
observed in the level of VB2, V~/3, V~4 (results not shown), 
and VB8.2 T cells in the three strains, it is very striking that 
the MA/MyJ mouse showed reduced V~6, V~7, VB8.1, and 
V~9 T cells, compared with the B10.BR mouse (Fig. 3). This 
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Figure 3.  Selected TCR Vfl gene usage in 
B10.BR, AKR, and MA/MyJ strains. Vfl6, 
7, 8.1, and 9 are absent in CD4 ÷ T cells (A) 
and reduced in CD8 + T cells (B) of the Mls- 
1-positive  strain  AKIk.  The  same  VBs  are 
highly  reduced  in  CD4 +  T  cells  of  the 
MA/MyJ mouse (A), while their reduction is 
not as pronounced  in CD8 + T  cells in this 
strain (B). The B10.BR strain is not depleted 
of these  four TCR  VBs (negative  control). 
VB8.2 is not deleted in either strain. 
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positive AKR mouse. However, while these four V/Ss were 
virtually absent form the CD4 + T  cells in the AKR mouse, 
only a partial deletion was seen in the MA/MyJ mouse, de- 
spite the fact that mice >4 mo of age were tested. The differ- 
ence in magnitude of deletion in AKR vs. MA/MyJ mice 
is even more noticeable in the CD8 + subset of T  cells. The 
incomplete deletion of the set of Mls-l-associated VBs in the 
MA/MyJ mouse is consistent with functional data obtained 
in in vitro stimulation assays; i.e., we have observed that sev- 
eral V~6 and VBS.1 T cell hybridomas are unable to respond 
to MA/MyJ-derived B cell blasts, while mounting a good 
response to Mls-1 (results not shown). The fact that MA/MyJ 
does not delete VB3 indicates that this mouse strain does not 
express an Mls-2,  Mls-3,  or Mls-4 phenotype. 
MMTV Profile of the MA/MyJ Mouse.  We had initially 
observed in Southern blot analysis  that the genome of the 
MA/MyJ  mouse does not contain Mtv-7,  but  has  a  new 
MMTV provirus (11), now designated Mtv-43. From the hy- 
bridization pattern seen in PvulI-digested chromosomal DNA, 
probed with an MMTV LTR fragment, we conclude that 
MA/MyJ mice have Mtv-8, -9, -I7,  and 29,  in addition to 
the unique Mtv-43 (Fig. 4 A). By probing the Southern blot 
with a DNA fragment that was isolated from the 3' flanking 
Table  2.  Segregation  Analysis of SAC Activity 
No. of  Percent  Percent 
mice  V/~6*  S.I.* 
B10.BIL 
(MA/MyJ  x  B10.BIL)F1 
Backcross mice 
B10.BR-like 
F~-like 
Discordant 
12  8.4  (0.30)  0 
13  1.7  (0.09)  100 
38  8.9 (0.19)  2 (1.14) 
58  1.9 (0.08)  85 (4.96) 
2  8.4  47 
3  3.2  9 
"  Percentage  of CD4 + T cells that express  V/36, as determined  by two- 
color flow cytometry. The numbers in parentheses are the SEM. 
Stimulation Index from MLR using B10.BR T  cells. Results are 
expressed as a percentage of the stimulation index (cpm [experimen- 
tal]/cpm[control])  obtained  with (MA/MyJ x B10. BR)F1 B cells. The 
numbers in parentheses are the SEM. 
region of Mtv-7 (11), we noticed that the hybridization pat- 
tern of  MA/MyJ is different from that of  Mtv-7-positive strains 
(Fig. 4 B). Thus, it is unlikely that Mtv-43 maps to the vi- 
cinity of Mtv-7 on chromosome 1, or that this new provirus 
is  a product of an Mtv-7 duplication. 
Segregation Analyses of tke MA/MyJ SAG Activity and 
Mtv-43.  We next examined whether the MA/MyJ SAG ac- 
tivity segregates with the newly identified MMTV provirus 
Mtv-43 in  backcross mice.  For this  purpose,  we  analyzed 
(MA/MyJ  x  B10.BR)Ft  x  B10.BR,  and  B10.BR  x 
(MA/MyJ  x  B10.BR)F1 mice for three parameters: (a)  In 
vitro MLR stimulatory activity, as measured by B10.BR T 
ceUs; (b) level of Vfl6 expression in the CD4 + T  cell subset; 
and (c) presence or absence of Mtv-43. The two types of  back- 
cross mice were used to test for potential maternal transmis- 
Figure 4.  MMTV  expression  analysis. (A) Genomic  DNA from  CBA/J, 
AKK, B10.BP,, and MA/MyJ mice was digested with lhrulI, Southern 
blotted, and hybridized  to a 32p-labeled  MMTV LTR.  probe. The junc- 
tion fragrae~ts  of the various MMTVs are marked. (B) Genomic  DNA 
from  MA/MyJ, B10.BK,  AKK, and CBA/J  mice  was digested  with Pvull, 
Southern blotted, and hybridized  with a 3zP-labded fragment, isolated 
from the M~7 3' flanking region. Molecular  mass markers are shown 
on the right. 
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Figure 5.  Segregation  analyses of the MA/MyJ superantigen  activity 
and Mt~43. (MA/MyJ x  B10.BR)Ft x  B10.B1L  backcross mice (101) 
were typed  for V~6 level  (x-axis), ability  to stimulate  B10.BR  T cells (y- 
axis) and presence  (filled  squares)  or absence (open  squares)  of Mt~43. The 
stimulation index  obtained  with (MA/MyJ x B10.BK)F1  B cells (100%). 
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ence in transmission ratio was observed in the two groups. 
The results obtained with 101 backcross mice are shown in 
Table  2  and Fig.  5. 
To normalize the MLR data,  the stimulatory activity of 
each backcross mouse is expressed as percentage of the stimula- 
tory activity of (MA/MyJ  x  B10.BR)F1 B cell blasts,  tested 
on B10.BR T  cells in the same experiment (100%  value). 
Despite variations seen in individual mice, there are dearly 
two groups of backcross mice that can be functionally dis- 
tinguished:  The Fl-like mice, which stimulate B10.BR  T 
cells and have a reduced number of V~/6 CD4 + T  cells (58 
mice), and the B10.BR-like mice, which have neither stimula- 
tory activity, nor delete V~6 T  cells (38 mice). This distri- 
bution fits segregation of the SAG phenotype as a single genetic 
trait at a 95% confidence level by X  2 analysis (27).  Five mice 
were discordant;  i.e.,  their stimulator), phenotype did not 
correlate completely with their level of V~6 cells. This may 
be a reflection of natural variations in the onset of pheno- 
typic expression of the MA/MyJ-specific SAG during ontogeny 
(see Fig. 2) and/or the variability of the assays used. Alterna- 
tively, other undefined factors may also influence the pheno- 
typic expression. 
Typing for Mtv-43 was done by Southern blotting of PvuII- 
digested genomic DNA, using an MMTV LTR probe (see 
Fig. 4 A). As is evident in Fig. 5, the presence of the Mtv-43 
provirus correlates well with the expression of the MA/MyJ- 
specific  SAG. 
Sequence Comparison of Mtv-43 and Mtv-7 sag.  We have 
recently cloned and sequenced the Mtv-7 sag gene and shown 
in transfection studies that it encodes Mls-1 (18a). It was of 
interest, therefore, to compare the Mtv-43 sag sequence with 
that  of Mtv-7.  For this purpose,  genomic DNA from the 
MA/MyJ strain was digested with PvuII, and DNA corre- 
sponding in size to the Mtv-43 junction fragment was iso- 
lated  from  an  agarose  gel  Its  specificity was  tested  in  a 
Southern blot that was hybridized with an MMTV LTR probe 
(Fig. 6). The MMTV sag sequences were amplified by PCR 
from nucleotide 343 through the 3' end, including 112 nucleo- 
tides of the 3' untranslated region. The 5' end was not ob- 
tained, because the comparison of other MMTV sag sequences 
indicates that they are all very homologous in this part of 
the gene (18a). The PCR products were cloned into M13mp18, 
and single-strand phage DNA was prepared from plaques that 
hybridized to an MMTV LTR probe. From the DNA shown 
in Fig. 6, lane A, which contained only the Mtv-43junction 
fragment, four independent full-length clones of identical 
nucleotide sequence were obtained. On the other hand, from 
the DNA shown in Fig.  6,  lane B,  which contained both 
the Mtv-17 and the Mtv-43junction fragments, two indepen- 
dent full-length clones of different nudeotide sequence were 
obtained,  one  corresponding  to  the Mtv-17 sag  sequence 
(Beutner, U., W. N. Frankel, M. S. Cole, J. M. Coffin, and 
B. T. Huber, unpublished data) (resuhs not shown), and the 
other corresponding to the sequence of the former four clones. 
Thus, we conjectured that this latter DNA sequence is de- 
rived from the Mtv-43 sag gene. Fig. 7 shows its nucleotide 
Figure6.  MMTV  specificityofisohted 
DNA  used as  PCR  template. PvulI- 
digested  genomic  DNA from MA/MyJ 
mice  was run on a low melt agarose  gel, 
the DNA corresponding  in size to the 
Mtv-43 junction fragment  was isolated, 
and part of  it was run again  on an agarose 
gel  (lanes A  and  B).  PvuII-digested 
genomic  DNA from  MA/MyJ  mice  was 
run as a control (lane C). The gel was 
Southern blotted and hybridized  with a 
32p-labeled MMTV LTR  probe. The 
MMTV  junction fragments  are marked. 
sequence, lined up with the corresponding Mtv-7 sag sequence 
(18a). The two genes are 97.8% homologous over a stretch 
of 688  nucleotides tested,  indicating that  they are closely 
related. To confirm the identity of the putative Mtv-43 sag 
sequence,  two  oligomers  were  synthesized  spanning  the 
nucleotide differences in the 3' end of the Mtv-7 and the Mtv-43 
sag genes. Using them as probes revealed they that hybrid- 
ized specifically to the respective  junction fragments of  Mtv-7 
and Mtv-43 in AKR and MA/MyJ genomic DNA (Fig.  8). 
The predicted amino acid sequence of the Mtv-43 sag gene 
was compared with that of other MMTV sag products (Fig. 
9). Interestingly, the COOH terminus has a high degree of 
homology in the Mtv-43 sag- and the Mtv-7 sag-derived pro- 
teins.  Over a stretch of 20 amino acids,  there are only two 
substitutions that have a minor impact on the structure, as 
they represent conservative changes. This is very striking, be- 
cause the COOH terminus of the Mtv-7 sag-encoded  pro- 
rein differs completely from that of all other MMTV sag gene 
products cloned and sequenced so far. 
Discussion 
The MA strain exhibited a high incidence of spontaneous 
mammary tumors (77% in breeding females and 64% in virgin 
females) and, thus, may have carried an infectious MMTV. 
The MA/MyJ strain, which is free of spontaneous carcino- 
genesis, was derived from a single MA female that did not 
develop mammary tumors (28).  This is of special interest, 
because the MA/MyJ strain contains a new MMTV provirus 
in its genome, now designated Mtv-43,  that is not present 
in other inbred strains (11). Most other endogenous MMTVs 
are  shared between various inbred  strains.  The infectious 
MMTV of the MA strain could have integrated into the germ- 
line,  resulting in  transmission  of a provirus in Mendelian 
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Figure 7.  NudeotidesequenceofMt~4]sag(nudeo- 
tides 376--1063), compared with that of M~7 sag. Iden- 
tical nucleotides are represented by dots. The lower- 
case letters after position 1009 indicate the beginning 
of the 3' untranslated  region.  The amino adds  are 
shown above. These sequence data are available from 
EMBL/GenBank/DDBJ  under  accession  number 
X64541. 
fashion. Unfortunately, this hypothesis cannot be tested, be- 
cause the original MA strain is no longer available. However, 
the fact that an infectious MMTV that has a very  similar 
sag sequence to Mtv-43 sag was recently isolated supports this 
idea (20@. The implication of this Ending is that the integrated 
provirus protects the animal from the infectious virus, prob- 
ably by deleting the T cells able to respond to the virus (29). 
This is plausible because it has been shown that only T cells 
are able to transfer the milk-borne infectious virus from its 
primary residence  in the gut to the mammary tissue (30). 
The striking finding is that the TCR VB deletion pattern 
in the mature T cell repertoire of the MA/MyJ mouse is iden- 
tical to that of Mls-1  strains; i.e.,  V/36-, 7-, 8.1-, and 9-ex- 
pressing CD4 + T cells are significantly reduced in MA/MyJ 
and virtually absent in Mls-1 mice.  This deletion pattern is 
seen in CD8 + T cells as well, but is less pronounced in the 
MA/MyJ mouse than in the Mls-l-positive AKR mouse. A 
difference is also noted in the time point when the stimula- 
tory activity of these two SAG can be functionally detected 
during ontogeny. The MA/MyJ-derived SAG appears much 
later in life than Mls-1. The disparate penetration of the two 
SAG phenotypes could be due to differences in the level of 
expression, controlled partially by cellular flanking sequences. 
Alternatively,  differences in the coding sequences of the two 
MMTV sag genes could lead  to  two products  that  differ 
slightly in their affinity for the TCR Vfl (see below). A similar 
delay in expression  has been noted for the SAG encoded by 
infectious MMTV (14, 16) (20a), but this may be due to the 
time needed for the accumulation of infectious virus in the 
relevant lymphocyte populations. 
The TCR Vfl deletion in vivo is a much more sensitive 
readout  of SAG expression  than in vitro stimulation of T 
cells expressing the particular Vfl chains. In fact, many SAG 
do not stimulate primary T cells at all, although they will 
stimulate selected T cell hybrids expressing the relevant TCR 
VB chains  (31).  We have made a similar observation  with 
the Mtv-43-encoded  SAG, which leads to efficient  deletion 
of VB6  CD4 +  T  cells  in vivo,  but  has  limited  in vitro 
stimulatory capacity (Fig.  1). This latter function can only 
reliably be measured by using LPS-induced B cell blasts,  a 
1618  Mtv-43 Encodes  an Mls-l-like Superantigen Figure 8.  Combination  of Mtv-43 sag Y nucleotide sequence. PvulI- 
digested DNA from AKR (lanes A, C, and E) and MA/MyJ (lanes B, 
D, and F) was subjected  to electrophoresis  and either  blotted and hybrid- 
ized to a 32p-labeled MMTV LTR probe (lanes A and B), or dried and 
hybridized to a 3zP-labeled  Mtv-7-specific  oligomer (lanes C and D) or an 
Mtv-43-spedfic oligomer (lanes E and F). The junction fragments of the 
various MMTVs are marked, and molecular  mass standards are shown  on 
the right. The relevant bands in lanes C and F, respectively, are marked 
('Mw-7 junction fragments in C;  **Mtv-43  junction fragment in F). 
treatment that has been demonstrated to increase the T cell 
stimulator],  capacity  of endogenous  SAG  (10).  We  have 
screened  a panel of V36 and V38.1 T  cell hybrids,  most of 
which were not stimulated by MA/MyJ-derived  B cells, al- 
though  they all reacted  to Mls-1  (results  not shown).  This 
is consistent with the partial deletion of V36 and V38.1  T 
cells  seen in MA/MyJ  mice in vivo. 
Since the TCR V3 deletion pattern of Mls-1 and the Mtv- 
43-encoded SAG is remarkably  similar,  it was of interest  to 
determine the nucleotide sequence of Mtv-43 sag and com- 
pare its predicted amino acid  sequence with that  of Mtv-7 
sag.  The finding that  the two genes are virtually identical 
offers an explanation for their functional similarity.  At the 
COOH  terminus,  only  2  of  20  residues  are  different, 
Mtv  7 
Mtv  43 
Mtv  1 
Mtv  8 
Mtv  9 
MMTV  C3H 
M~  BR  6 
MMTV  GR 
Mtv  7 
Mtv  43 
Mtv  1 
Mtv  8 
MtV  9 
MMTV  C3H 
MMTV  BR  6 
MMTV  GR 
MtV  7 
Mtv  43 
Mtv  1 
MtV  8 
Mtv  9 
MMTV  C3H 
MMTV  BR  6 
MMTV  GR 
Mtv  7 
i01  150 
GPQPTSSYKF  HRFCPSEIEI  RMLAKNYIFT  NKTNPIGRLL  ITMLRNESLP 
............  L ..................  E  .........  14  .......  S 
............  L ............................  M .......  S 
.............  Y ...........................  I ........ 
........................................  V ........  S 
...........  QP  ...........................  V  ......... 
............  I..L .........  K ..............  V  ........  S 
151  200 
FSTIFTQIQR  LEMGIENRKR  RSTAVKEQVQ  GLSATGLEVK  EGKRSVFVKI 
.......................  S .......................... 
.......................  S.E ......  R.S .....  R .... AL... 
.......................  S.E ......  R.S .....  R .... TL, .  . 
........................................  K ......... 
.........  K  .............  SIE ......  LT ......  K..K  ...... 
....................  H..S.E  ......  R.S .....  R .... AL... 
.........  K  ............  KSIE  ......  L.S .....  K..K  ...... 
201  250 
GDRWWQPGTY  RGPYIYRPTD  APLPYTGRYD  LNFDR~"gTVN  GYKVLYRSLP 
.................................  N ................ 
......  L .........................  W ................. 
.................................................  S 
.......  R  ........................  w  .....  I  ........... 
251  299 
FRERLARARp  PWCVLTQEEK  DDMKQQVHDY  IYLGTGM-NF  WGKIFDYTEE 
Mtv 
Mtv 
Mtv  8 
Mtv  9 
M~4TV  C3H 
MMTV  BR  6 
MMTV  GR 
Mtv  7 
Mtv  43 
Mtv  1 
Mtv  8 
Mtv  9 
MMTV  C3H 
MMTV  BR  6 
M]4TV  GR 
43  .....................................  -  ............ 
1 ................ S  ...................... IH  .-.V.YNSR. 
...................... I  ................  V  ..... H,.K, 
.......................................  V  ..... H,.K, 
.............  M,S  ......................  H  ......  H-,K, 
.............  M  ......  N  ................  SSI  .....  H-,K, 
.............  M..EK  ....................  H  ....  V.H-,K. 
300  323 
GAIAKILY~  KYTHGGRVGF  DPF* 
..V ...........  N..I  .....  * 
E.KRHIIEHI  .ALP* 
..V.RQ.EHI  SADTF.MSYN  G* 
..V,RL.EHI  SADTF.MSYN  G* 
.TV.GLIEHY  SPKTY.MSYY  E* 
RTV.ALIEHY  SAKTY.MSYY  D* 
....  GLIEHY  SAKTY.MSYY  D" 
Figure 9.  Comparison  of the predicted  amino  acid sequence  Mtv-43 sag 
(residues 112-323) with that of nine other  MMTV sag products. Identical 
amino acids are represented  by dots, and gaps are represented  by dashes. 
representing conservative  changes and,  thus, probably have 
a limited influence on the secondary  structure.  However, as 
mentioned above, the two SAG, although very similar, differ 
slightly in their antigenic  strength.  It is possible that  this 
is caused  by  these conservative  amino acid  changes. 
As can be seen in Fig. 9, most of the heterogeneity in the 
predicted  MMTV sag sequences  occurs at the COOH  ter- 
minus. The COOH-terminal sequence shared by Mtv-7 and 
Mtv-43 sag products is completely different from other infec- 
tious and endogenous MMTV sag sequences published. The 
shared V/3 deletion pattern and 3' sequences provide a strong 
indication that the V3 specificity of SAG molecules is deter- 
mined by the COOH terminus. The fact that  an infectious 
MMTV  has  been  isolated  that  is very  similar  to  the  two 
MMTV  proviruses  Mtv-7  and Mtv-43  indicates  a common 
origin of these  three  viruses  (20a). 
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